GR1002847B - Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως - Google Patents
Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεωςInfo
- Publication number
- GR1002847B GR1002847B GR970100172A GR970100172A GR1002847B GR 1002847 B GR1002847 B GR 1002847B GR 970100172 A GR970100172 A GR 970100172A GR 970100172 A GR970100172 A GR 970100172A GR 1002847 B GR1002847 B GR 1002847B
- Authority
- GR
- Greece
- Prior art keywords
- micropostol
- erection
- problems related
- therapeutic
- acid
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 abstract 1
- 229960005249 misoprostol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR97100172 | 1997-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1002847B true GR1002847B (el) | 1998-01-27 |
Family
ID=10942965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970100172A GR1002847B (el) | 1997-05-06 | 1997-05-06 | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6210343B1 (el) |
| EP (1) | EP0980245B1 (el) |
| JP (1) | JP2001525803A (el) |
| AT (1) | ATE261307T1 (el) |
| AU (1) | AU6848098A (el) |
| DE (2) | DE69822295T2 (el) |
| ES (1) | ES2216279T3 (el) |
| GR (1) | GR1002847B (el) |
| PT (1) | PT980245E (el) |
| WO (1) | WO1998050039A1 (el) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1002847B (el) | 1997-05-06 | 1998-01-27 | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
| US7087240B1 (en) * | 1998-06-25 | 2006-08-08 | Lavipharm Laboratories Inc. | Device and method for the treatment of erectile dysfunction |
| GR1003199B (el) | 1998-08-14 | 1999-09-01 | Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες | |
| US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
| AU3713600A (en) | 1999-03-01 | 2000-09-21 | Nitromed, Inc. | Nitrosated and nitrosylated prostaglandins, compositions and metods of use |
| US7479120B2 (en) * | 2002-02-22 | 2009-01-20 | Hans Gregersen | Method and apparatus for investigating force-deformation properties in muscles in walls of bodily hollow systems |
| US8287474B1 (en) | 2002-08-22 | 2012-10-16 | Koenig J Frank | Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body |
| US7037257B1 (en) * | 2002-08-22 | 2006-05-02 | Koenig J Frank | Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications |
| GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| US20050255161A1 (en) * | 2004-05-10 | 2005-11-17 | Servet Buyuktimkin | Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water |
| GB0417401D0 (en) * | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| CA2610465A1 (en) * | 2005-06-03 | 2006-12-14 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same |
| GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| JP2010095454A (ja) * | 2008-10-14 | 2010-04-30 | Cyclochem:Kk | 抗菌組成物 |
| WO2010070617A1 (en) * | 2008-12-19 | 2010-06-24 | Shimoda Biotech (Pty) Ltd | Inclusion complexes of alpha-cyclodextrin and sildenafil salt |
| RU2428933C1 (ru) * | 2010-02-19 | 2011-09-20 | Государственное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени акад. И.П. Павлова Федерального агентства по здравоохранению и социальному развитию" | Способ определения индекса функциональной достаточности артериального кровенаполнения кавернозной ткани по результатам ультрасонографии полового члена |
| RU2444989C1 (ru) * | 2010-09-27 | 2012-03-20 | Государственное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития России) | Способ диагностики васкулогенной эректильной дисфункции |
| WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
| IT201600119871A1 (it) * | 2016-11-25 | 2018-05-25 | Sabatino Russo | Uso dell’associazione di inibitori della fosfodiesterasi 5 con prostaglandina e1 per il trattamento della disfunzione erettile |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000894A1 (en) * | 1991-07-03 | 1993-01-21 | Scott Nathan E | Prostaglandin e2 treatment of impotence |
| US5510384A (en) * | 1993-02-12 | 1996-04-23 | Mckee; Rex N. | Method of treating damaged mucosal and epithelial tissues with misoprostol |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4696821A (en) | 1983-10-11 | 1987-09-29 | Warner-Lambert Company | Transdermal delivery system for administration of nitroglycerin |
| US5256652A (en) | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
| US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
| PT97441B (pt) | 1990-04-25 | 1998-08-31 | Alza Corp | Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral |
| US5962528A (en) | 1991-07-03 | 1999-10-05 | Scott; Nathan Earl | Prostaglandin E2 /F2α combination for treating impotence |
| US5252602A (en) * | 1991-10-11 | 1993-10-12 | Rafeul Alam | Effects of misoprostol on allergic responses |
| BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
| US5773457A (en) * | 1995-02-15 | 1998-06-30 | Cesar Roberto Dias Nahoum | Compositions |
| US6007836A (en) | 1993-05-28 | 1999-12-28 | Vericade, Inc. | Transdermal vasodilator |
| FR2710649A1 (fr) | 1993-09-30 | 1995-04-07 | Germinal Sarl | Film polymérique à base de prolamines, son procédé de préparation et ses applications . |
| KR100422191B1 (ko) | 1994-08-05 | 2004-05-20 | 인파머 에스. 에이. | 포스페티딜콜린과착물화된프로스타글란딘e1및/또는트록세루틴을함유하는발기불능국부치료용조성물 |
| US5612359A (en) | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
| CN1126587A (zh) | 1995-01-10 | 1996-07-17 | 王怀秀 | 经阴囊睾酮缓释系统 |
| NZ305560A (en) | 1995-03-14 | 1998-11-25 | Vivus Inc | Method for preventing erectile dysfunction by administering vasoactive agent, particularly a prostaglandin, kit therefor |
| US5731339A (en) | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
| AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
| US5688499A (en) | 1996-03-13 | 1997-11-18 | Queen's University At Kingston | Antagonism of endothelin actions |
| US5684177A (en) | 1996-05-17 | 1997-11-04 | Torcan Chemical Ltd. | Misoprostol |
| GR1002847B (el) | 1997-05-06 | 1998-01-27 | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
| US5976566A (en) | 1997-08-29 | 1999-11-02 | Macrochem Corporation | Non-steroidal antiinflammtory drug formulations for topical application to the skin |
| EP1027057A4 (en) | 1997-10-28 | 2003-01-02 | Vivus Inc | TREATMENT OF FEMALE SEXUAL DISORDERS |
| US6046244A (en) | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
| US6277884B1 (en) | 1998-06-01 | 2001-08-21 | Nitromed, Inc. | Treatment of sexual dysfunction with N-hydroxyguanidine compounds |
| US5942545A (en) | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
| EP1136072A4 (en) | 1998-12-02 | 2004-12-15 | Mochida Pharm Co Ltd | PREPARATION FOR ADMINISTRATION IN THE URINARY LADDER |
| EP1108426A3 (en) | 1999-12-02 | 2002-10-02 | Pfizer Products Inc. | Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| US6323241B1 (en) | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| EP1268000A4 (en) | 2000-03-23 | 2004-12-29 | Merck & Co Inc | SPIROPIPERID DERIVATIVES AS MELANOCORTIN RECEPTOR AGONISTS |
| US6476037B1 (en) | 2000-03-23 | 2002-11-05 | The Regents Of The University Of California | L-arginine and phosphodiesterase (PDE) inhibitor synergism |
| AU4929601A (en) | 2000-03-23 | 2001-10-03 | Merck & Co Inc | Substituted piperidines as melanocortin receptor agonists |
| WO2002009717A1 (en) | 2000-07-31 | 2002-02-07 | Ono Pharmaceutical Co., Ltd. | Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient |
-
1997
- 1997-05-06 GR GR970100172A patent/GR1002847B/el not_active IP Right Cessation
-
1998
- 1998-04-22 DE DE69822295T patent/DE69822295T2/de not_active Expired - Fee Related
- 1998-04-22 ES ES98913967T patent/ES2216279T3/es not_active Expired - Lifetime
- 1998-04-22 DE DE0980245T patent/DE980245T1/de active Pending
- 1998-04-22 PT PT98913967T patent/PT980245E/pt unknown
- 1998-04-22 US US09/423,130 patent/US6210343B1/en not_active Expired - Fee Related
- 1998-04-22 AU AU68480/98A patent/AU6848098A/en not_active Abandoned
- 1998-04-22 JP JP54785598A patent/JP2001525803A/ja active Pending
- 1998-04-22 WO PCT/GR1998/000012 patent/WO1998050039A1/en not_active Ceased
- 1998-04-22 AT AT98913967T patent/ATE261307T1/de not_active IP Right Cessation
- 1998-04-22 EP EP98913967A patent/EP0980245B1/en not_active Expired - Lifetime
-
2000
- 2000-02-02 US US09/496,710 patent/US6589990B1/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000894A1 (en) * | 1991-07-03 | 1993-01-21 | Scott Nathan E | Prostaglandin e2 treatment of impotence |
| US5510384A (en) * | 1993-02-12 | 1996-04-23 | Mckee; Rex N. | Method of treating damaged mucosal and epithelial tissues with misoprostol |
Non-Patent Citations (1)
| Title |
|---|
| ANON.: "Alprostadil for erectile impotence.", DRUG AND THERAP. BULL., vol. 33, no. 8, 1995, pages 61 - 62, XP002049460 * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69822295D1 (de) | 2004-04-15 |
| PT980245E (pt) | 2004-06-30 |
| EP0980245B1 (en) | 2004-03-10 |
| US6589990B1 (en) | 2003-07-08 |
| ES2216279T3 (es) | 2004-10-16 |
| JP2001525803A (ja) | 2001-12-11 |
| WO1998050039A1 (en) | 1998-11-12 |
| ATE261307T1 (de) | 2004-03-15 |
| AU6848098A (en) | 1998-11-27 |
| DE980245T1 (de) | 2000-08-31 |
| EP0980245A1 (en) | 2000-02-23 |
| US6210343B1 (en) | 2001-04-03 |
| DE69822295T2 (de) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR1002847B (el) | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
| BR0014652A (pt) | Fabricação de conjugados de agente terapêutico-poliglutamato | |
| PT934058E (pt) | Forma estavel de medicamento para a administracao por via oral com derivados de benzimidazole como substancia activa e processo para a sua producao | |
| MY125821A (en) | Pharmaceutical composition of topiramate | |
| IS1858B (is) | Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur | |
| DE58906926D1 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung. | |
| ATE235895T1 (de) | Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis | |
| AU1534699A (en) | Osmotic dosage form comprising first and second coats | |
| CA2386690A1 (en) | Pharmaceutical tramadol salts | |
| BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
| DE59802670D1 (de) | Osmotisches arzneimittelfreisetzungssystem | |
| BR9811086A (pt) | Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica | |
| EA199900734A1 (ru) | Микрокапсулы, содержащие цис-платину | |
| TW261615B (el) | ||
| AU1935788A (en) | A process for producing an administration and/or dosage form for medically active ingredients of drugs | |
| BR0008076A (pt) | 16-hidroxiestratrienos como estrogênios de efeito seletivo | |
| ES2191449T3 (es) | Derivados de ciclopentabenzofurano y su uso. | |
| FR2717081B1 (fr) | Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro. | |
| HUP9901659A2 (hu) | Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására | |
| Fischer et al. | Severe contact dermatitis due to nitroglycerin patches | |
| BR0107881A (pt) | Uso de fsh tratamento de infertilidade | |
| PT1144420E (pt) | Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao | |
| EG17992A (en) | Preparation of a medicament for arthritis and theumatism | |
| ATE203903T1 (de) | Delta-aminolävulinsäure enthaltendes arzneimittel | |
| GR1003199B (el) | Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |
Effective date: 20121204 |